Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model.
Sci Rep
; 6: 30439, 2016 07 27.
Article
em En
| MEDLINE
| ID: mdl-27460883
ABSTRACT
Arteriovenous fistulas (AVF) for hemodialysis access have a 1-year primary patency rate of only 60%, mainly as a result of maturation failure that is caused by insufficient outward remodeling and intimal hyperplasia. The exact pathophysiology remains unknown, but the inflammatory vascular response is thought to play an important role. In the present study we demonstrate that targeted liposomal delivery of prednisolone increases outward remodeling of the AVF in a murine model. Liposomes accumulate in the post-anastomotic area of the venous outflow tract in which the vascular pathology is most prominent in failed AVFs. On a histological level, we observed a reduction of lymphocytes and granulocytes in the vascular wall. In addition, a strong anti-inflammatory effect of liposomal prednisolone on macrophages was demonstrated in vitro. Therefore, treatment with liposomal prednisolone might be a valuable strategy to improve AVF maturation.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Prednisolona
/
Fístula Arteriovenosa
/
Remodelação Vascular
/
Inflamação
/
Veias Jugulares
Limite:
Animals
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article